The latest closing stock price for Verve Therapeutics as of September 18, 2024 is 5.51.
An investor who bought $1,000 worth of Verve Therapeutics stock at the IPO in 2021 would have $-827 today, roughly -1 times their original investment - a -44.32% compound annual growth rate over 3 years.
The all-time high Verve Therapeutics stock closing price was 73.99 on September 10, 2021.
The Verve Therapeutics 52-week high stock price is 20.12, which is 265.2% above the current share price.
The Verve Therapeutics 52-week low stock price is 4.30, which is 22% below the current share price.
The average Verve Therapeutics stock price for the last 52 weeks is 9.61.
An investor who bought $1,000 worth of Verve Therapeutics stock at the IPO in 2021 would have $-827 today, roughly -1 times their original investment - a -44.32% compound annual growth rate over 3 years.
The all-time high Verve Therapeutics stock closing price was 73.99 on September 10, 2021.
The Verve Therapeutics 52-week high stock price is 20.12, which is 265.2% above the current share price.
The Verve Therapeutics 52-week low stock price is 4.30, which is 22% below the current share price.
The average Verve Therapeutics stock price for the last 52 weeks is 9.61.